Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland

• Main Authors: Paul Thoueille (Author), Susana Alves Saldanha (Author), Fabian Schaller (Author), Aline Munting (Author), Matthias Cavassini (Author), Dominique Braun (Author), Huldrych F. Günthard (Author), Katharina Kusejko (Author), Bernard Surial (Author), Hansjakob Furrer (Author), Andri Rauch (Author), Pilar Ustero (Author), Alexandra Calmy (Author), Marcel Stoeckle (Author), Manuel Battegay (Author), Catia Marzolini (Author), Pascal Andre (Author), Monia Guidi (Author), Thierry Buclin (Author), Laurent A. Decosterd (Author), on behalf of the Swiss HIV Cohort Study (Author)
• Format: Book
• Published: MDPI AG, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

SHCS#879 is an ongoing Switzerland-wide multicenter observational study conducted within the Swiss HIV Cohort Study (SHCS) for the prospective follow-up of people living with HIV (PLWH) receiving long-acting injectable cabotegravir-rilpivirine (LAI-CAB/RPV). All adults under LAI-CAB/RPV and part of...